- Home
- CKPT vs INSE Comparison
CKPT vs INSE Comparison
Compare CKPT & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- INSE
- Stock Information
- Founded
- CKPT 2014
- INSE N/A
- Country
- CKPT United States
- INSE United States
- Employees
- CKPT N/A
- INSE N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- INSE Computer Software: Prepackaged Software
- Sector
- CKPT Health Care
- INSE Technology
- Exchange
- CKPT Nasdaq
- INSE Nasdaq
- Market Cap
- CKPT 214.4M
- INSE 245.3M
- IPO Year
- CKPT 2017
- INSE N/A
- Fundamental
- Price
- CKPT $3.61
- INSE $8.52
- Analyst Decision
- CKPT Strong Buy
- INSE Buy
- Analyst Count
- CKPT 3
- INSE 3
- Target Price
- CKPT $10.33
- INSE $15.00
- AVG Volume (30 Days)
- CKPT 2.4M
- INSE 158.1K
- Earning Date
- CKPT 11-12-2024
- INSE 11-07-2024
- Dividend Yield
- CKPT N/A
- INSE N/A
- EPS Growth
- CKPT N/A
- INSE N/A
- EPS
- CKPT N/A
- INSE N/A
- Revenue
- CKPT $47,000.00
- INSE $297,900,000.00
- Revenue This Year
- CKPT N/A
- INSE N/A
- Revenue Next Year
- CKPT $151,162.55
- INSE $4.15
- P/E Ratio
- CKPT N/A
- INSE N/A
- Revenue Growth
- CKPT N/A
- INSE N/A
- 52 Week Low
- CKPT $1.38
- INSE $7.51
- 52 Week High
- CKPT $4.50
- INSE $11.00
- Technical
- Relative Strength Index (RSI)
- CKPT 41.64
- INSE 28.92
- Support Level
- CKPT $2.98
- INSE $8.99
- Resistance Level
- CKPT $4.44
- INSE $9.20
- Average True Range (ATR)
- CKPT 0.42
- INSE 0.39
- MACD
- CKPT -0.10
- INSE -0.12
- Stochastic Oscillator
- CKPT 25.66
- INSE 5.13
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.